Refurbished Dna Sequencing Platforms Market Size, Share, Industry Trends and Forecast to 2030

Refurbished DNA Sequencing Platforms Market Size & CAGR in 2021

The global refurbished DNA sequencing platforms market is expected to have a growth rate of 5.2% CAGR from 2021 to 2026. As a result, the market is anticipated to reach a value of USD 2.3 billion by 2026.

COVID-19 Impact on the Refurbished DNA Sequencing Platforms Market

The COVID-19 pandemic has had a significant impact on the refurbished DNA sequencing platforms market. The pandemic led to disruptions in the supply chain, affecting the production and distribution of refurbished DNA sequencing platforms. However, the increased focus on genomic research and sequencing to understand the virus and develop vaccines has also created opportunities for growth in the market.

Refurbished DNA Sequencing Platforms Dynamics

The refurbished DNA sequencing platforms market is driven by the increasing demand for cost-effective solutions for genetic analysis in research, clinical diagnostics, and other applications. Refurbished platforms offer an affordable alternative to purchasing new equipment, making them attractive to smaller research labs and clinics. Additionally, advancements in sequencing technology and the growing awareness of personalized medicine are fueling the growth of the market.

Segments and Related Analysis

The refurbished DNA sequencing platforms market can be segmented based on platform type, application, end-user, and region. Platform types include Sanger sequencing and next-generation sequencing platforms. Applications of refurbished DNA sequencing platforms include research, clinical diagnostics, forensics, and others. End-users of these platforms include academic and research institutions, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

By Region Analysis

In terms of regional analysis, North America currently dominates the refurbished DNA sequencing platforms market, driven by the presence of key market players, technological advancements, and government initiatives to promote genomics research. Europe and Asia Pacific are also significant regions in the market, with increasing investments in healthcare infrastructure and research and development activities.

Key Market Players and Competitive Landscape

Some of the key players in the refurbished DNA sequencing platforms market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Qiagen, and PerkinElmer. These companies are actively involved in product development, mergers and acquisitions, and partnerships to strengthen their market position and expand their product offerings.

Recent Happenings in the Refurbished DNA Sequencing Platforms Market

- In January 2021, Illumina announced the launch of the NovaSeq 6000 System, a cost-effective and high-throughput sequencing platform for genomic research. - In March 2021, Thermo Fisher Scientific introduced the Ion GeneStudio S5 Series, a scalable sequencing platform for targeted gene analysis and other applications. - In August 2021, Qiagen partnered with the University of Oxford to develop next-generation sequencing solutions for COVID-19 research and surveillance. - In November 2021, Agilent Technologies acquired Resolution Bioscience, a company specializing in liquid biopsy and non-invasive cancer diagnostics, to expand its genomics portfolio.